Additionally, by immunofluorescence analysis we observed that expression of AR after testosterone treatment was decreased in BPH-1 cells treated with 5-HT, 5-Htr1a and 5-Htr1b specific agonists (Supplementary Fig. 2). The gene discussed is AR; the disease is benign prostatic hyperplasia.